Background: Approximately 2–4% of individuals worldwide with diabetes mellitus have foot ulcers. This study aims to assess the factors affecting the outcomes of severe foot ulcers in diabetic individuals. Methods: An analytical prospective cohort study was conducted from March 1st, 2015, to March 1st, 2017. A total of 34 individuals was selected. The study included patients with foot ulcers below the ankle who were at risk of amputation. All tests used a <5% level of significance and confidence interval of 95%. A Pearson’s chi-squared test and binary multiple regression were performed to assess the factors related to healing. Results: Only 11.7% of the individuals required amputation; ulcers classified as 2/B according to the University of Texas Diabetic Foot Ulcer Classification System healed before the 1/B ulcers. Neuropathic ulcers were the most prevalent (58.8%); 61.8% healed after 1 year. Most of the individuals were overweight, 47.1% had reduced glomerular filtration rates, and 78.8% had glycated hemoglobin >7%. Body mass index and osteomyelitis were the two significant variables in logistic regression. Conclusions: In this study, osteomyelitis was the main complication related to the risk of amputation, and elevated body mass index and osteomyelitis were the significant factors that induced a slower healing time.
OBJECTIVE:To assess the prevalence of altered ankle-brachial index (<0.9 or >1.3) in patients with type 1 diabetes and to compare it with the presence of subclinical atherosclerosis by carotid ultrasound. METHODS:Prospective, cross-sectional study in which 45 adults with type 1 diabetes were evaluated (age 34±10 years, 46.7% men).The data collected included anamnesis, clinical evaluation, calculation of the ankle-brachial index (relationship between systolic blood pressure in the ankle and brachial artery), and performance of carotid ultrasound.RESULTS: Thirty-two patients had ankle-brachial index >1.3 (66.7%) and no patient had ankle-brachial index <0.9. Carotid echocardiography was performed on 21 patients, 4 (19%) of whom had atherosclerosis. Age >35 years and ankle-brachial index >1.4 showed a good correlation with atherosclerosis (r=0. 49, p=0.021; r=0.56, p=0.008, respectively). A model associating age >35 years and ankle-brachial index >1.4 showed an excellent relationship with atherosclerosis (r=0.59, p=0.004). CONCLUSIONS:Our study showed that vascular calcification (ankle-brachial index >1.4) was frequent in this population with type 1 diabetes and associated with subclinical atherosclerosis. A model combining ankle-brachial index >1.4 and age >35 years showed an excellent correlation with atherosclerosis and can assist in clinical suspicion and optimize the request for additional tests.
Introduction: Diabetes, a chronic metabolic disease with high prevalence in Brazil, is a risk factor for severe SARS COV-2 infection. The relationship between previous glycemic control and the prognosis of patients hospitalized with COVID-19 is not fully understood. Objective: analyze the clinical outcome of patients with diabetes mellitus infected by SARS-COV-2. Outlining: A retrospective analysis of medical records was carried out using the Trakcare electronic system of all diabetic patients hospitalized with a confirmatory diagnosis of pneumonia due to COVID-19 in the medical clinic ward of HRAN, from June to August 2021, who, upon admission, performed the glycated hemoglobin test and analyzed it using the SPSS software (20.0). Results: A sample of 52 patients was obtained during the study period. Most patients are female, with a mean age of approximately 58 years. The comorbidity most associated with the participants was systemic arterial hypertension, with most diabetics presenting good prior glycemic control, represented by HbA1c ≤ 7%. The lethality found was 7.7%. Implications: The study shows a high lethality of diabetic patients infected by COVID 19, but no statistical significance was found for HbA1c levels with the increase in length of stay, use of non-rebreathing mask, need for invasive mechanical ventilation or lethality
Objetivo: Descrever as características clinicas, endoscópicas e abordagem terapêutica de crianças com o diagnóstico de Aspiração de Corpo Estranho (ACE) atendidos na Emergência da Broncoesofagologia -HBDF. Métodos:Estudo descritivo e retrospectivo, baseado em prontuários de pacientes com ACE atendidos na Emergência da Broncoesofagologia-HBDF( janeiro de 2012 a janeiro de 2015). Foram consideradas crianças neste estudo pacientes com idade < 18 anos. Foram analisadas as variavéis: sexo, idade, características do corpo estranho(CE) aspirado(tipo e localização), clínica, radiologia, tratamento, complicações e mortalidade.Resultados: 51 pacientes tiveram o diagnóstico de ACE. 45(88,2%) com idade < 18 anos (crianças). Entre as crianças, a ACE predominou no sexo masculino (73,3%) e na faixa etária de 1-3 anos (53,3%). Sementes foram os CE mais aspirados (40%). Houve predomínio da ACE na arvore brônquica direita (46,4%). Tosse e dispnéia após engasgo foram as queixas principais. Dezoito (40%) possuiam CE radiopacos ao Rx-tórax. A broncoscopia rígida sob anestesia geral foi utilizada em 95,5%. Dois pacientes necessitaram de UTI devido insuficiência respiratória aguda pela ACE e dois por desconforto respiratório secundário à laringoespasmo ou edema glótico-subglótico pós-procedimento. Cinco(11,1%) menores possuiam pneumonia e um bronquiectasias como complicação pelo CE na arvore traqueobrônquica. Não houve óbito e procedimento cirúrgico aberto para remoção do CE.Conclusões: ACE foi um acidente predominante nos pacientes pediátricos ( principalmente meninos com idade entre 1-3 anos). Sementes foram os CE mais aspirados. Houve predominância da ACE na arvore brônquica direita. A broncoscopia mostrou-se segura e eficaz no tratamento.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.